Sexual Health and Quality of Life in Patients With Low-Risk Early-Stage Cervical Cancer: Results From GCIG/CCTG CX.5/SHAPE Trial Comparing Simple Versus Radical Hysterectomy

S Sarah E. Ferguson (Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada) L Lori A. Brotto J Janice Kwon (University of British Columbia, Vancouver, British Columbia, Canada) V Vanessa Samouëlian (Gynecologic Oncology, Centre Hospitalier de l’Université de Montréal (CHUM), Centre de Recherche de l’Université de Montréal (CRCHUM), Université de Montréal, Montreal, QC, Canada) G Gwenael Ferron (Institut Claudius Regaud, IUCT-Oncopole and GINECO, Toulouse, France) A Amandine Maulard (Gustave Roussy Cancer Center, Villejuif, France) C Cor de Kroon (Department of Gynaecology, Leiden University Medical Center, Leiden, the Netherlands) W Willemien Van Driel (Center for Gynecologic Cancer, Amsterdam, the Netherlands) J John Tidy (Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom) K Karin Williamson (Nottingham University Hospitals, Nottingham, United Kingdom) S Sven Mahner (LMU University Hospital, Department of Obstetrics and Gynecology, Munich, Germany) S Stefan Kommoss (Diakonie-Klinikum Stuttgart Hospital, Stuttgart, Germany) F Frederic Goffin K Karl Tamussino (Medical University of Graz, Graz, Austria) B Brynhildur Eyjolfsdottir (Oslo University Hospital, Oslo, Norway) J Jae-Weon Kim (Department of Obstetrics and Gynecology, Seoul National University, College of Medicine, Seoul, South Korea) N Noreen Gleeson (St James' Hospital, Dublin, Ireland) D Dongsheng Tu (Canadian Cancer Trials Group, Queen’s University, Kingston, ON, Canada) L Lois Shepherd (Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada) M Marie Plante (Centre Hospitalier Universitaire de Quebec, L'Hotel-Dieu de Quebec, Quebec, Canada)

Abstract

PURPOSE Simple hysterectomy and pelvic node assessment (SHAPE) is a phase III randomized trial (ClinicalTrials.gov identifier: NCT01658930 ) reporting noninferiority of simple compared with radical hysterectomy for oncologic outcomes in low-risk cervical cancer. This study presents secondary outcomes of sexual health and quality of life (QOL) of the SHAPE trial. METHODS Participants were randomly assigned to receive either radical or simple hysterectomy. Sexual health was assessed up to 36 months postoperatively using the Female Sexual Function Index (FSFI) and Female Sexual Distress Scale-Revised and QOL using European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 and Cervical Cancer-Specific Module (QLQ-CX24) questionnaires. RESULTS Among participants with at least one QOL measure, clinical and pathologic characteristics were balanced and with no differences in preoperative baseline scores for sexual health or QOL between groups. FSFI total score met the cutoff for dysfunction up to 6 months ( P = .02) in the radical hysterectomy group. Group differences favored simple hysterectomy for FSFI subscales: desire and arousal at 3 months ( P ≤ .001) and pain and lubrication up to 12 months ( P ≤ .018). Both groups met the cutoff for sexual distress but was higher in radical hysterectomy at 3 months ( P = .018). For QLQ-CX24, symptom experience was significantly better up to 24 months ( P = .031) and body image better at 3, 24, and 36 months ( P ≤ .01) for simple hysterectomy. Sexual-vaginal functioning was significantly better up to 24 months ( P ≤ .022) and more sexual activity up to 36 months ( P = .024) in the simple hysterectomy arm. Global health status was significantly higher at 36 months for simple hysterectomy ( P = .025). CONCLUSION Simple hysterectomy was associated with lower rates of sexual dysfunction than radical hysterectomy, with a lower proportion of women having sustained sexual-vaginal dysfunction. These results further support the benefit of surgical de-escalation for low-risk cervical cancer.

Article Details

Volume / Issue Vol. 43, Issue 2
Published January 10, 2025
Pages 167-179
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (20)

S

Sarah E. Ferguson

Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada

L

Lori A. Brotto

J

Janice Kwon

University of British Columbia, Vancouver, British Columbia, Canada

V

Vanessa Samouëlian

Gynecologic Oncology, Centre Hospitalier de l’Université de Montréal (CHUM), Centre de Recherche de l’Université de Montréal (CRCHUM), Université de Montréal, Montreal, QC, Canada

G

Gwenael Ferron

Institut Claudius Regaud, IUCT-Oncopole and GINECO, Toulouse, France

A

Amandine Maulard

Gustave Roussy Cancer Center, Villejuif, France

C

Cor de Kroon

Department of Gynaecology, Leiden University Medical Center, Leiden, the Netherlands

W

Willemien Van Driel

Center for Gynecologic Cancer, Amsterdam, the Netherlands

J

John Tidy

Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom

K

Karin Williamson

Nottingham University Hospitals, Nottingham, United Kingdom

S

Sven Mahner

LMU University Hospital, Department of Obstetrics and Gynecology, Munich, Germany

S

Stefan Kommoss

Diakonie-Klinikum Stuttgart Hospital, Stuttgart, Germany

F

Frederic Goffin

K

Karl Tamussino

Medical University of Graz, Graz, Austria

B

Brynhildur Eyjolfsdottir

Oslo University Hospital, Oslo, Norway

J

Jae-Weon Kim

Department of Obstetrics and Gynecology, Seoul National University, College of Medicine, Seoul, South Korea

N

Noreen Gleeson

St James' Hospital, Dublin, Ireland

D

Dongsheng Tu

Canadian Cancer Trials Group, Queen’s University, Kingston, ON, Canada

L

Lois Shepherd

Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada

M

Marie Plante

Centre Hospitalier Universitaire de Quebec, L'Hotel-Dieu de Quebec, Quebec, Canada